Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Citalopram can prolong the QT interval on an ECG, and in rare cases this may lead to dangerous heart rhythm problems such as torsades de pointes, an effect that is dose dependent. Risk is higher with doses above 40 mg daily (above 20 mg for people over 60, those with liver impairment, or slow CYP2C19 metabolizers), and in people with existing heart disease, low potassium or magnesium, or who take other QT-prolonging medications. Fainting, pounding or irregular heartbeat, severe dizziness, or sudden shortness of breath warrant urgent medical attention, while citalopram should never be stopped abruptly without guidance. Because individual risk varies widely and several important factors and warning signs apply, see below for the full details before drawing any conclusions about your own situation.
Since palpitations and dizziness can stem from medication effects, anxiety itself, electrolyte issues, or an unrelated heart condition, a free, instant, online symptom check can help you clarify what your symptoms most likely mean and decide how urgently to se
Citalopram is a commonly prescribed selective serotonin reuptake inhibitor (SSRI) used to treat depression, anxiety disorders and other mood conditions. Like all medications, it carries potential risks as well as benefits. One area of concern that’s received attention from researchers and regulators is the possibility that citalopram can affect heart rhythm. In this article we’ll explain:
By understanding the facts—and working closely with your doctor—you can make informed decisions about your treatment.
Every heartbeat starts with an electrical signal in the heart’s upper chambers (atria) and travels through to the lower chambers (ventricles). On an electrocardiogram (ECG), the “QT interval” measures the time it takes for your ventricles to contract and then recover.
• A normal QT interval ensures the heart resets properly before the next beat.
• If the QT interval is too long, it can predispose you to a dangerous rhythm called torsades de pointes, which can lead to fainting or, in rare cases, sudden cardiac arrest.
Citalopram can interfere with the electrical channels in heart cells that control how calcium, sodium and potassium move in and out of those cells. This interference may slow the recovery phase of each heartbeat, prolonging the QT interval.
Key points from credible sources (FDA, peer-reviewed studies):
Not everyone taking citalopram will experience heart rhythm problems. However, certain factors can raise your risk:
• High dose: Doses above 40 mg/day increase the chance of QT prolongation.
• Older age: Over 60, your body may clear citalopram more slowly.
• Existing heart disease: Conditions such as heart failure, prior heart attack or congenital long QT syndrome.
• Electrolyte imbalances: Low potassium, magnesium or calcium levels.
• Other medications: Some antibiotics, antifungals, antipsychotics or other antidepressants also prolong the QT interval.
• Liver impairment: Affects how quickly your body breaks down citalopram.
• Genetic factors: Certain inherited traits can predispose to prolonged QT even at lower drug levels.
If you have one or more of these factors, your doctor may recommend a lower starting dose, regular ECG monitoring or choosing a different antidepressant.
Many people with mild QT prolongation won’t notice any symptoms. If QT prolongation progresses to torsades de pointes or another dangerous rhythm, you might experience:
If any of these occur—especially fainting spells or severe dizziness—seek medical attention immediately.
Before starting citalopram, your doctor should:
During treatment, your doctor may:
To minimize your risk of heart rhythm issues on citalopram:
• Follow your prescription exactly—don’t increase your dose without medical advice.
• Tell your doctor about all other medications, supplements and herbal products you take.
• Stay hydrated and eat a balanced diet rich in potassium (bananas, spinach) and magnesium (nuts, seeds).
• Avoid alcohol binges, which can worsen electrolyte imbalances.
• Report any new symptoms—especially palpitations, dizziness or fainting—right away.
• If you miss a dose, take it as soon as you remember, unless it’s almost time for the next dose; do not double up.
If you experience any of the following, contact your healthcare provider or go to the nearest emergency department:
For less urgent concerns—new side effects that aren’t life-threatening—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
While QT prolongation is a valid concern, it affects only a small percentage of people on citalopram—and often those with additional risk factors. For many patients, the benefits of relief from depression and anxiety outweigh the potential heart risks. Never stop or change your medication without talking to your doctor first; abrupt discontinuation of citalopram can cause withdrawal symptoms.
Citalopram can cause QT interval prolongation and, in rare cases, dangerous heart rhythms—especially at high doses or in people with underlying risk factors. By working closely with your doctor, having appropriate testing and following safe-use practices, you can lower your risk while still benefiting from the medication’s effects on mood.
If you have any concerns about chest symptoms, fainting spells or other serious issues, speak to your doctor or seek medical attention right away. Never ignore symptoms that could signal a life-threatening problem. Your health and safety come first.
(References)
* Lam RW. Author response. J Psychiatry Neurosci. 2013 Jul;38(4):E11-2. doi: 10.1503/jpn.130055. PMID: 23791141; PMCID: PMC3692727.
* Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother. 2013 Oct;47(10):1330-41. doi: 10.1177/1060028013501994. Epub 2013 Oct 21. PMID: 24259697.
* Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93. PMID: 24549548; PMCID: PMC4086818.
* Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014 May;75(5):e441-9. doi: 10.4088/JCP.13r08672. PMID: 24922496.
* Ray WA, Chung CP, Murray KT, Hall K, Stein CM. High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death. J Clin Psychiatry. 2017 Feb;78(2):190-195. doi: 10.4088/JCP.15m10324. PMID: 27736049; PMCID: PMC5916769.
* Beach SR, Celano CM, Sugrue AM, Adams C, Ackerman MJ, Noseworthy PA, Huffman JC. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics. 2018 Mar-Apr;59(2):105-122. doi: 10.1016/j.psym.2017.10.009. Epub 2017 Nov 3. PMID: 29275963.
* Talibi S, Douglas C, Pope B. Cardiac Syncope with Anoxic Seizure Activity. Case Rep Emerg Med. 2020;2020:6749382. doi: 10.1155/2020/6749382. Epub 2020 Jan 8. PMID: 31976092; PMCID: PMC6970508.
* Létinier L, Bezin J, Jarne A, Pariente A. Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study. Drug Saf. 2023 May;46(5):449-456. doi: 10.1007/s40264-023-01283-7. Epub 2023 Apr 12. PMID: 37046156.
* Warrings W, Taurines R, Egberts K, Keicher F, Romanos M, Fekete S. Correlation Between Escitalopram, Sertraline, and Fluoxetine Serum Levels and QTc Interval Prolongation in Children and Adolescents. Ther Drug Monit. 2026 Jun 1;48(3):366-372. doi: 10.1097/FTD.0000000000001379. Epub 2025 Sep 26. PMID: 41004670.
* Chien HT, Lin SW, Kung TJ, Wang CC, Dong YH, Hwang TJ, Lin FJ, Toh S. Ventricular Arrhythmia and Sudden Death Risk With Concomitant Antipsychotic and SSRI Use. JAMA Netw Open. 2026 Apr 1;9(4):e266028. doi: 10.1001/jamanetworkopen.2026.6028. Epub 2026 Apr 1. PMID: 41954932; PMCID: PMC13067012.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.